June 02, 2025

Only 20% Account for 80% of Steroid Use: Study

In a UK-wide analysis of nearly 2 million patients, researchers found that “a fifth of patients receiving corticosteroids accounted for over 80% of oral and inhaled corticosteroid prescribing,” highlighting concentrated use and variable treatment persistence across formulations.

Conexiant

May 30, 2025

Major Medical Societies Issue GLP-1 Nutrition Guidelines

New advisory addresses nutritional challenges and side effects for obesity treatment

Conexiant

May 29, 2025

Long-Term Steroids in COPD Raise Health Risks

A study of over 500,000 patients found that using inhaled corticosteroids for more than 2 years in COPD significantly increased the risk of diabetes, pneumonia, fractures, cataracts, and osteoporosis.

Conexiant

May 28, 2025

Kennedy Proposes NIH Publishing Ban

"We're probably going to stop publishing in The Lancet, New England Journal of Medicine, JAMA, and those other journals because they're all corrupt."

Conexiant

May 28, 2025

Tool May Help to Predict Low Grip Strength in Seniors 

Researchers developed a clinically validated tool that predicts low handgrip strength in older adults using 12 common health and lifestyle factors, enabling early identification and targeted intervention.

Conexiant

May 16, 2025

Delandistrogene Moxeparvovec: Efficacy Evidence Questioned

The AAN Guidelines Subcommittee review finds delandistrogene moxeparvovec for DMD failed to meet primary functional outcomes despite FDA approval.

Conexiant

May 15, 2025

Assistant Professor Salary Gaps Persist Nationwide

Persistent salary disparities by gender, race, and ethnicity were identified among more than 45,000 U.S. assistant professors, with underrepresented in medicine women learning the least across all specialties.

Conexiant

November 18, 2024

Leptin's Role in Energy Deficiency Syndromes

Researchers present new insights into Relative Energy Deficiency in Sport, emphasizing its impact on athletes and military personnel, and discussing potential prevention and treatment strategies.

Conexiant

December 10, 2024

Hormone Therapy Risks Vary: Tibolone Linked to Arterial Events

Recent study links tibolone use in menopausal hormone therapy to a 52% increased cardiovascular disease risk, emphasizing the need for tailored hormone therapy approaches and further research in BMJ.

Conexiant